Sunday, 18 April 2021 18:32

Earnings Outlook: Here’s how the ‘pause’ on J&J’s COVID-19 shot may or may not affect the company’s earnings

Rate this item
(0 votes)
To what degree will Johnson & Johnson’s COVID-19 vaccine manufacturing issues and the federal 'pause' over safety concerns weigh on investors' mind when the company reports earnings next week?

Read more from our friends at MarketWatch

Read 447 times